References
- Jabs DA, Nussenblatt RB, Rosenbaum JT. Group S of UN (sun) W. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005;140:509–516.
- Nussenblatt RB, Palestine AG, Chan CC, Roberge F. Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology. 1985;92(4):467–471. doi:https://doi.org/10.1016/S0161-6420(85)34001-0.
- Forrester J. Uveitis: pathogenesis. Lancet. 1991;338(8781):1498–1501. doi:https://doi.org/10.1016/0140-6736(91)92309-P.
- Foster CS, Charles S, Vitale AT. Diagnosis and Treatment of Uveitis. Philadelphia, PA: W.B. Saunders; 2002:900.
- Kimura SJ, Thygeson P, Hogan MJ. Signs and symptoms of uveitis. II. Classification of the posterior manifestations of uveitis. Am J Ophthalmol. 1959;47(5):171–176. doi:https://doi.org/10.1016/S0002-9394(14)78240-6.
- Denniston AK, Holland GN, Kidess A, et al. Heterogeneity of primary outcome measures used in clinical trials of treatments for intermediate, posterior, and panuveitis. Orphanet J Rare Dis. 2015;10(1):97. doi:https://doi.org/10.1186/s13023-015-0318-6.
- Lowder CMDP, Belfort RJMD, Lightman SMD, et al. Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis. Arch Ophthal. 2011;129(5):545. doi:https://doi.org/10.1001/archophthalmol.2010.339.
- Kempen JH, Van Natta ML, Altaweel MM, et al. Factors predicting visual acuity outcome in intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment (MUST) trial. Am J Ophthalmol. 2015;160(6):1133–1141.e9. doi:https://doi.org/10.1016/j.ajo.2015.09.017.
- Jaffe GJ, Dick AD, Brézin AP, et al. Adalimumab in patients with active noninfectious uveitis. N Engl J Med. 2016;375(10):932–943. doi:https://doi.org/10.1056/NEJMoa1509852.
- Nguyen QD, Merrill PT, Jaffe GJ, et al. Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial. Lancet. 2016;388(10050):1183–1192. doi:https://doi.org/10.1016/S0140-6736(16)31339-3.
- Hornbeak DM, Payal a, Pistilli M, et al. Interobserver agreement in clinical grading of vitreous haze using alternative grading scales. Ophthalmology. 2014;121(8):1643–1648. doi:https://doi.org/10.1016/j.ophtha.2014.02.018.
- Kempen JH, Ganesh SK, Sangwan VS, Rathinam SR. Interobserver agreement in grading activity and site of inflammation in eyes of patients with uveitis. Am J Ophthalmol. 2008;146(6):813–818. doi:https://doi.org/10.1016/j.ajo.2008.06.004.
- Denniston AK, Keane PA, Srivastava SK. Biomarkers and surrogate endpoints in uveitis: the impact of quantitative imaging. Invest Ophthalmol Vis Sci. 2017;58(6):BIO131–BIO140. doi:https://doi.org/10.1167/iovs.17-21788.
- Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8(5):336–341. doi:https://doi.org/10.1016/j.ijsu.2010.02.007.
- Liu X, Moore D, Denniston A. Instrument-based tests for measuring vitreous inflammation in uveitis: a systematic review. https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=84168. Published February 19, 2018. Accessed April 1, 2020.
- Haring G, Nolle B, Wiechens B. Ultrasound biomicroscopic imaging in intermediate uveitis. Br J Ophthalmol. 1998;82(6):625–629. doi:https://doi.org/10.1136/bjo.82.6.625.
- Doro D, Manfre a, Deligianni V, Secchi AG. Combined 50- and 20-MHz frequency ultrasound imaging in intermediate uveitis. Am J Ophthalmol. 2006;141(5):953–955. doi:https://doi.org/10.1016/j.ajo.2005.11.048.
- Madow B, Galor a, Feuer WJ, Altaweel MM, Davis JL. Validation of a photographic vitreous haze grading technique for clinical trials in uveitis. Am J Ophthalmol. 2011;152(2):170–176.e1. doi:https://doi.org/10.1016/j.ajo.2011.01.058.
- Keane PA, Karampelas M, Sim DA, et al. Objective measurement of vitreous inflammation using optical coherence tomography. Ophthalmology. 2014;121(9):1706–1714. doi:https://doi.org/10.1016/j.ophtha.2014.03.006.
- Keane PA, Balaskas K, Sim DA, et al. Automated analysis of vitreous inflammation using spectral-domain optical coherence tomography. Transl Vis Sci Technol. 2015;4(5):4. doi:https://doi.org/10.1167/tvst.4.5.4.
- Zarranz-Ventura J, Keane PA, Sim DA, et al. Evaluation of objective vitritis grading method using optical coherence tomography: influence of phakic status and previous vitrectomy. Am J Ophthalmol. 2016;161:172–180e4. doi:https://doi.org/10.1016/j.ajo.2015.10.009.
- Sreekantam S, Macdonald T, Keane PA, Sim DA, Murray PI, Denniston AK. Quantitative analysis of vitreous inflammation using optical coherence tomography in patients receiving sub-Tenon’s triamcinolone acetonide for uveitic cystoid macular oedema. Br J Ophthalmol. 2017;101(2):175–179. doi:https://doi.org/10.1136/bjophthalmol-2015-308008.
- Coric D, Ometto G, Montesano G, et al. Objective quantification of vitreous haze on optical coherence tomography scans: no evidence for relationship between uveitis and inflammation in multiple sclerosis. Eur J Neurol. 2020;27(1):144–e3. doi:https://doi.org/10.1111/ene.14048.
- Mahendradas P, Madhu S, Kawali A, et al. Enhanced vitreous imaging in uveitis. Ocul Immunol Inflamm. 2017;27(1):1–7.
- Oksala A. Ultrasonic findings in the vitreous body in patients with acute anterior uveitis. Acta Ophthalmol. 1977;55(2):287–293. doi:https://doi.org/10.1111/j.1755-3768.1977.tb01310.x.
- Davis JL, Madow B, Cornett J, et al. Scale for photographic grading of vitreous haze in uveitis. Am J Ophthalmol. 2010;150(5):5.doi:https://doi.org/10.1016/j.ajo.2010.05.036.
- Passaglia CL, Arvaneh T, Greenberg E, Richards D, Madow B. Automated method of grading vitreous haze in patients with uveitis for clinical trials. Transl Vis Sci Technol. 2018;7(2):10. doi:https://doi.org/10.1167/tvst.7.2.10.
- Nanavaty MA, Stanford MR, Sharma R, Dhital a, Spalton DJ, Marshall J. Use of the double-pass technique to quantify ocular scatter in patients with uveitis: a pilot study. Ophthalmologica. 2010;225(1):61–66. doi:https://doi.org/10.1159/000316690.
- Dickson D, Agarwal a, Sadiq MA, et al. Assessment of vitreous haze using ultra-wide field retinal imaging. J Ophthalmic Inflamm Infect. 2016;6(1):1.doi:https://doi.org/10.1186/s12348-016-0105-0.
- Jones NP. The manchester uveitis clinic: the first 3000 patients, 2: uveitis manifestations, complications, medical and surgical management. Ocul Immunol Inflamm. 2015;23(2):127–134. doi:https://doi.org/10.3109/09273948.2014.968671.
- American Uveitis Society UCLA Stein Eye Institute. UCLA/AUS workshop on objective measures of intraocular inflammation.
- Spalton DJ. Ocular fluorophotometry. Br J Ophthalmol. 1990;74(7):431–432. doi:https://doi.org/10.1136/bjo.74.7.431.
- Cunha-Vaz JG. Vitreous fluorophotometry recordings in posterior segment disease. Graefes Arch Clin Exp Ophthalmol. 1985;222(4–5):241–247. doi:https://doi.org/10.1007/BF02133688.